J44.9 J96.19
Conditions
Interventions
Group 1: Single-arm study (see inclusion/exclusion criteria). Demographic data, data on the current disease status, the disease-specific quality of life as well as lung function and respiratory muscle
Sponsors
Kliniken der Stadt Köln gGmbH, Lungenklinik Standort-Merheim
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with pre-existing and newly diagnosed COPD of any stage according to GOLD with established home NIV therapy. Deventilation syndrome defined as morning dyspnea symptoms after cessation of NIV therapy Consent to privacy policy and patient education. Verbal and cognitive ability to respond to questionnaires
Exclusion criteria
Exclusion criteria: Exclusion criteria: Patient age <18 years Alexia, deafness Patients not capable of giving consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is the comparison of bodyplethysmographic and respiratory muscular parameters before and after four hours of NIV use. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints are the comparison of the evaluation of the data from the patient catalog, as well as the SRI questionnaire and the ventilator settings and device data. | — |
Countries
Germany
Contacts
Public ContactMaximilian Wollsching-Strobel
Kliniken der Stadt Köln gGmbH, Lungenklinik Standort-Merheim, Universität Witten/Herdecke
Outcome results
None listed